Разрешен к применению с 1995 года.
Видео о
Купить в
COVID-19 
По алфавиту
B Göhring, D Riemann, U Rebmann, H Heynemann, J Schabel, J Langner
Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FUUrol Res. 1996;24(5):297-303.
Baer M.R., George S.L., Caligiuri M.A. et al.
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.J Clin Oncol. 2008 Oct 20;26(30):4934-9. doi: 10.1200/JCO.2008.17.0472. Epub 2008 Jun 30.
Balkhi, S.; Bilato, G.; De LermaBarbaro,A. et al. 
PDF
Vaccines 2025, 13, 69.
Barni S, Lissoni P, Cazzaniga M et al.
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates.Oncology. 1995 May-Jun;52(3):243-5. doi: 10.1159/000227465. PMID: 7715908.
Bauer D, Wasmuth S, Hermans P. et al.
On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation.Exp Eye Res. 2007 Sep;85(3):335-45. Epub 2007 Jun 14.
Belyakova K.L., Stepanova O.I., Sheveleva A.R. et al. PDF
Interaction of NK Cells, Trophoblast, and Endothelial Cells during Angiogenesis.
Cell Technologies in Biology and Medicine. — No. 1, May. — 2019. — P. 169-176.
Bendickova K., Fric J. PDF
J Leukoc Biol. 2020 Jul; 108(1): 427–437.
Berezhko V., Rudneva О., Uspensky V. , Sasikova R.
Иммуномодуляторы в комплексе с антигеном из протосколексов echinococcus multilocularis в профилактике экспериментального альвеолярного эхинококкоза.Meditsinskaia parazitologiia i parazitarnye bolezni. – 2017.08.20.
Bernson E., Hallner A., Sander F.E. et al.
Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.Leukemia. 2017 Dec;31(12):2552-2559. doi: 10.1038/leu.2017.151.
Bersanelli M, Buti S, Camisa R et al.
Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy.Cancers (Basel). 2014 Sep 30;6(4):2035-48. doi: 10.3390/cancers6042035. PMID: 25271833; PMCID: PMC4276955.
Bert W O’Malley Jr, Daqing Li, Shelly J McQuone, Robert Ralston
Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedsideLaryngoscope. 2005 Mar;115(3):391-404.
Beverly J Lange, Richard K Yang, Jacek Gan, Jaquelyn A Hank, Eric L Sievers, Todd A Alonzo, Robert B Gerbing, Paul M Sondel
Soluble interleukin-2 receptor α activation in a Children’s Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemiaPediatr Blood Cancer. 2011 Sep;57(3):398-405.
Bluestone JA.
The yin and yang of interleukin-2-mediated immunotherapy.N Engl J Med. 2011 Dec 1;365(22):2129-31. doi: 10.1056/NEJMe1110900. PMID: 22129258.
Boldt DH, Mills BJ, Gemlo BT et al.
Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans.Cancer Res. 1988 Aug 1;48(15):4409-16. PMID: 3260537.
Bonnet B. et. al PDF
Journal of immunology. — Volume 197, Issue 1, Pages 188-198. DOI: 10.4049/jimmunol.1501271
Boubnova N., Smirnov M., Petrov S.
Clinical application of Roncoleukin® (interleukin-2).
Abstacts book of 5th Sci. Meeting of Europ. Soc. of chemotherapy inf. diseases. S.-Petersburg, 1997. P. 36 (B016).
Brendan Curti, Gregory A Daniels, David F McDermott, Joseph I Clark, Howard L Kaufman, Theodore F Logan, Jatinder Singh, Meenu Kaur, Theresa L Luna, Nancy Gregory, Michael A Morse, Michael K K Wong, Janice P Dutcher
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIM SM registryJ Immunother Cancer. 2017 Dec 19;5(1):102.
Bukhtoyarov O., Samarin D. PDF
European Journal of Medical and Health Sciences. – 2021. – Vol 3, Issue 4. – P. 73-79. DOI: http://dx.doi.org/10.24018/ejmed.2021.3.4.960
Buyse M., Squifflet P., Lange B.J. et al.
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.Blood (2011) 117 (26): 7007-7013.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.